The current stock price likely implies Botox declines, but we think the franchise can maintain healthy growth as a result of expansion of the market and limited price competition. Firms Likely to Have ...

Shares of Irvine-based Allergan Inc. jumped Monday as Wall Street got its first crack at the stock after word Friday that the company’s flagship Botox drug was approved as a treatment for migraine ...

CHICAGO (Reuters) - Allergan Inc said on Thursday that its popular Botox facial wrinkle-smoother worked as a treatment for adults suffering from chronic migraines, according to late-stage clinical ...

Allergan Inc. saw a smoother first quarter for Botox and sales of other medical cosmetic products, which took a hit during the recession. Stronger sales of wrinkle-fighting Botox as well as skin ...

Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. A federal jury July 18 said Revance Therapeutics' skin ...

U.S. District Judge Eli Richardson in Nashville, Tennessee, ruled, opens new tab that Allergan plausibly alleged that Revance had acquired and used some of its rival’s trade secrets amid a series of ...

IRVINE, Calif. (CBS.MW) -- Shares of Allergan jumped 6 percent Monday after the specialty pharmaceutical company announced it won a highly anticipated regulatory approval to market its Botox drug as a ...

Botox is a prescription drug used to reduce wrinkles and treat medical conditions such as overactive bladder and chronic migraine. The drug comes as a powder and is diluted with saline before it’s ...

We’re adding branded drug giant Allergan (AGN), which is based in Ireland, to our model portfolio, says biotech and healthcare sector expert Bret Jensen, editor of Investors Alley’s Biotech Gems.